DK1575559T3 - Doseringsaerosoler med lecithin som overfladeaktivt stof - Google Patents
Doseringsaerosoler med lecithin som overfladeaktivt stofInfo
- Publication number
- DK1575559T3 DK1575559T3 DK03799507T DK03799507T DK1575559T3 DK 1575559 T3 DK1575559 T3 DK 1575559T3 DK 03799507 T DK03799507 T DK 03799507T DK 03799507 T DK03799507 T DK 03799507T DK 1575559 T3 DK1575559 T3 DK 1575559T3
- Authority
- DK
- Denmark
- Prior art keywords
- lecithin
- surfactant
- dosage aerosols
- aerosols
- dosage
- Prior art date
Links
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 title abstract 2
- 239000000443 aerosol Substances 0.000 title abstract 2
- 229940067606 lecithin Drugs 0.000 title abstract 2
- 235000010445 lecithin Nutrition 0.000 title abstract 2
- 239000000787 lecithin Substances 0.000 title abstract 2
- 239000004094 surface-active agent Substances 0.000 title abstract 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000001282 iso-butane Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10260882A DE10260882B4 (de) | 2002-12-24 | 2002-12-24 | Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1575559T3 true DK1575559T3 (da) | 2006-11-27 |
Family
ID=32667543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03799507T DK1575559T3 (da) | 2002-12-24 | 2003-12-24 | Doseringsaerosoler med lecithin som overfladeaktivt stof |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060073103A1 (fr) |
| EP (1) | EP1575559B1 (fr) |
| JP (1) | JP2006517190A (fr) |
| CN (1) | CN1728984A (fr) |
| AT (1) | ATE335467T1 (fr) |
| AU (1) | AU2003300230A1 (fr) |
| DE (2) | DE10260882B4 (fr) |
| DK (1) | DK1575559T3 (fr) |
| ES (1) | ES2270166T3 (fr) |
| IL (1) | IL169356A0 (fr) |
| TW (1) | TW200423969A (fr) |
| WO (1) | WO2004058221A1 (fr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5292499A (en) * | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
| GB9118830D0 (en) * | 1991-09-03 | 1991-10-16 | Minnesota Mining & Mfg | Medical aerosol formulations |
| JP2001511160A (ja) * | 1997-02-05 | 2001-08-07 | ヤゴ リサーチ アクチェンゲゼルシャフト | 医学用エアゾール配合物 |
| US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
| ES2234266T3 (es) * | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
| US6312665B1 (en) * | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
| DE19911064A1 (de) * | 1999-03-12 | 2000-09-14 | Ig Spruehtechnik Gmbh | Dosieraerosole mit Isobutan als Treibmittel |
-
2002
- 2002-12-24 DE DE10260882A patent/DE10260882B4/de not_active Expired - Fee Related
-
2003
- 2003-12-18 TW TW092135946A patent/TW200423969A/zh unknown
- 2003-12-24 CN CNA2003801071841A patent/CN1728984A/zh active Pending
- 2003-12-24 JP JP2004563206A patent/JP2006517190A/ja active Pending
- 2003-12-24 US US10/540,648 patent/US20060073103A1/en not_active Abandoned
- 2003-12-24 EP EP03799507A patent/EP1575559B1/fr not_active Expired - Lifetime
- 2003-12-24 DE DE50304615T patent/DE50304615D1/de not_active Expired - Fee Related
- 2003-12-24 DK DK03799507T patent/DK1575559T3/da active
- 2003-12-24 AT AT03799507T patent/ATE335467T1/de not_active IP Right Cessation
- 2003-12-24 AU AU2003300230A patent/AU2003300230A1/en not_active Abandoned
- 2003-12-24 WO PCT/EP2003/014901 patent/WO2004058221A1/fr not_active Ceased
- 2003-12-24 ES ES03799507T patent/ES2270166T3/es not_active Expired - Lifetime
-
2005
- 2005-06-23 IL IL169356A patent/IL169356A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2270166T3 (es) | 2007-04-01 |
| IL169356A0 (en) | 2007-07-04 |
| EP1575559A1 (fr) | 2005-09-21 |
| CN1728984A (zh) | 2006-02-01 |
| TW200423969A (en) | 2004-11-16 |
| WO2004058221A1 (fr) | 2004-07-15 |
| DE50304615D1 (de) | 2006-09-21 |
| ATE335467T1 (de) | 2006-09-15 |
| US20060073103A1 (en) | 2006-04-06 |
| AU2003300230A1 (en) | 2004-07-22 |
| DE10260882A1 (de) | 2004-09-30 |
| DE10260882B4 (de) | 2007-02-08 |
| JP2006517190A (ja) | 2006-07-20 |
| EP1575559B1 (fr) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| CY1111821T1 (el) | Φαρμακευτικες συνθeσεις οι οποιες περιλαμβανουν ενα οπιουχο αναλγητικο | |
| CL2008002407A1 (es) | Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04). | |
| DE60019167D1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| AP2003002916A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
| ATE342053T1 (de) | Formulierungen zur inhalation | |
| ES2189410T3 (es) | Formulacion farmaceutica en aerosol. | |
| DK1363641T3 (da) | Progestagen, der er co-mikroniseret med et overfladeaktivt middel, farmaceutisk præparat, som indeholder det, fremgangsmåder til fremstilling deraf samt anvendelser deraf | |
| BR0207025B1 (pt) | derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo. | |
| UA88477C2 (ru) | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение | |
| DE60311920D1 (de) | Aufgabevorrichtung mit Dosierkammer sowie Aerosolspender mit derselben | |
| DK1608336T3 (da) | Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler | |
| NO992102L (no) | Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen | |
| ECSP077126A (es) | Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores | |
| USD529537S1 (en) | Type font | |
| WO2003102012A3 (fr) | Nouveaux esters d'etonogestrel | |
| ITMI20000010A0 (it) | Dispositivo per la somministrazione di aerosol dosati pressurizzati in propellenti idrofluoroalcani | |
| DE60324205D1 (de) | Wasserlöslicher behälter | |
| DE60136637D1 (en) | Topische polymere antimikrobielle emulsion | |
| AR038560A1 (es) | Una composicion antitranspirante/ desodorante | |
| ITRM20020477A1 (it) | Procedimento per la realizzazione di un fantoccio stereolitografato biomorfo, multicompartimentale e per esami multianalitici, e relativo dispositivo. | |
| ITPR20020027A1 (it) | Ampolla nebulizzatrice, in particolare per aerosolterapia. | |
| DK1575559T3 (da) | Doseringsaerosoler med lecithin som overfladeaktivt stof | |
| NO20052478D0 (no) | Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse. | |
| NO20053110D0 (no) | 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler. |